LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer

Conclusion: Taken together, these results approved that LPS and IL-8 activated neutrophils from UCB may be the novel strategy in immune therapy for ovarian cancer.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Qi Liu, Weihong Yang, Ning Luo, Jie Liu, Yuliang Wu, Jinye Ding, Caixia Li, Zhongping Cheng Tags: Research Paper Source Type: research